• 대한생식의학회:학술대회논문집
• /
• 대한불임학회 2006년도 The 5th Biannual Meeting of Pacific Rim Society for Fertility and Sterility
• /
• pp.114-116
• /
• 2006

• 대한생식의학회:학술대회논문집
• /
• 대한불임학회 2006년도 The 5th Biannual Meeting of Pacific Rim Society for Fertility and Sterility
• /
• pp.18-20
• /
• 2006

• 한국유전체학회:학술대회논문집
• /
• 한국유전체학회 2005년도 The 14th Korea Genome Conference
• /
• pp.48-48
• /
• 2005

• Clinical and Experimental Reproductive Medicine
• /
• 제30권2호
• /
• pp.135-139
• /
• 2003

Objective: We investigated whether serum testosterone to estradiol ratio was decreased in infertile men and whether this condition can be corrected with oral aromatase inhibitor. Method: The serum testosterone to estradiol ratio of 26 men with testicular failure were compared with those of normal semen analysis parameter, 89 control reference group. All of 26 testicular failure group were diagnosed with the previous testicular biopsy. Then 46 men with oligospermia and/or asthenospermia were selected and treated with 1 mg of the aromatase inhibitor anastrozole ($Arimidex^{(R)}$) orally once daily for 3 months. Testosterone to estradiol ratio and semen analyses were evaluated during anastrozole therapy. Results: The testosterone level of testicular failure group was significantly lower and the testosterone to estradiol ratio was more decreased than normal semen parameter group. Forty six on-anastrozole group had significantly lower testosterone (4.6 versus 5.7 ng/ml, p<0.01) and higher estradiol (15.9 versus 23.4 pg/ml, p<0.01) than pre-anastrozole group, resulting in a decreased testosterone to estradiol ratio ($0.21{\pm}0.07$ versus $0.39{\pm}0.15$, p<0.01). Semen analyses before and during anastrozole treatment revealed significant increases in sperm count (35.5 versus 52.2 million sperm per ml, p<0.01) and motility (22.9% versus 29.3%, p<0.01). Conclusions: We identified infertile men with testicular failure had hormonal changes characterized by a decreased serum testosterone to estradiol ratio. The ratio can be corrected with aromatase inhibitor, resulting in a significant improvement in semen parameters.

• Clinical and Experimental Reproductive Medicine
• /
• 제25권3호
• /
• pp.281-286
• /
• 1998

Premature ovarian failure is a condition causing amenorrhea, hypoestrogenism, and elevated gonadotropins in women younger than 40 years. Many causes of premature ovarian failure were reported, including genetic abnormalities, enzymatic defects, defects in gonadotropin secretion or action, autoimmune disorders, physical and idiopathic causes. Recently, Finnish group reported a point mutation in the follicle stimulating hormone (FSH) receptor gene in premature ovarian failure patients. But it was reported that the group from United States could not find any mutation in FSH receptor gene. So we analysed C566T point mutation of FSH receptor gene using restriction fragment length polymorphism (RFLP) and compared the result between premature ovarian failure patient with idiopathic and known causes. But we did not find 556C${\rightarrow}$T mutation in the FSH receptor gene in both groups. These findings suggest that the missense mutation in the human FSH receptor gene reported in Finnish women with premature ovarian failure is uncommon in Korean women with premature ovarian failure.

• Clinical and Experimental Reproductive Medicine
• /
• 제44권4호
• /
• pp.187-192
• /
• 2017

Although the survival rate of hematologic malignancies in young patients is very high, cytotoxic therapies such as chemotherapy and total body irradiation therapy can significantly reduce a patient's reproductive capacity and cause irreversible infertility. Early ovarian failure also commonly occurs following additional cancer treatment, bone marrow transplantation, or autologous transplantation. Because the risk of early ovarian failure depends on the patient's circumstances, patients with a hematologic malignancy must consult health professionals regarding fertility preservation before undergoing treatments that can potentially damage their ovaries. While it is widely known that early menopause commonly occurs following breast cancer treatment, there is a lack of reliable study results regarding fertility preservation during hematologic malignancy treatment. Therefore, an in-depth discussion between patients and health professionals about the pros and cons of the various options for fertility preservation is necessary. In this study, we review germ cell toxicity, which occurs during the treatment of hematologic malignancies, and propose guidelines for fertility preservation in younger patients with hematologic malignancies.

• Clinical and Experimental Reproductive Medicine
• /
• 제44권2호
• /
• pp.96-104
• /
• 2017

Objective: This study aimed to compare the clinical outcomes between in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in sibling oocytes. Additionally, we evaluated whether the implementation of split insemination contributed to an increase in the number of ICSI procedures. Methods: A total of 571 cycles in 555 couples undergoing split insemination cycles were included in this study. Among them, 512 cycles (89.7%) were a couple's first IVF cycle. The patients were under 40 years of age and at least 10 oocytes were retrieved in all cycles. Sibling oocytes were randomly allocated to IVF or ICSI. Results: Total fertilization failure was significantly more common in IVF cycles than in ICSI cycles (4.0% vs. 1.4%, p<0.05), but the low fertilization rate among retrieved oocytes (as defined by fertilization rates greater than 0% but < 30%) was significantly higher in ICSI cycles than in IVF cycles (17.2% vs. 11.4%, p<0.05). The fertilization rate of ICSI among injected oocytes was significantly higher than for IVF ($72.3%{\pm}24.3%$ vs. $59.2%{\pm}25.9%$, p<0.001), but the fertilization rate among retrieved oocytes was significantly higher in IVF than in ICSI ($59.2%{\pm}25.9%$ vs. $52.1%{\pm}22.5%$, p<0.001). Embryo quality before embryo transfer was not different between IVF and ICSI. Although the sperm parameters were not different between the first cycle and the second cycle, split insemination or ICSI was performed in 18 of the 95 cycles in which a second IVF cycle was performed. Conclusion: The clinical outcomes did not differ between IVF and ICSI in split insemination cycles. Split insemination can decrease the risk of total fertilization failure. However, unnecessary ICSI is carried out in most split insemination cycles and the use of split insemination might make ICSI more common.

• Natural Product Sciences
• /
• 제6권1호
• /
• pp.5-10
• /
• 2000

The chloroform extract of the seeds of Carica papaya has been screened for the hormonal properties using ovariectomized female rats for estrogenicity, estrogen primed immature rats for progestogenicity and castrated adult male rats for androgenicity. The results revealed that the extract lacks progestogenicity and androgenicity as evident from the failure of the extract treated animals to mimic progestogen and androgen related changes in the target tissues. The increased weight of vagina and uterus, open status of vagina, cornified and epithelial cells in the vaginal smears and hypertrophy in the uterine epithelium, endometrium and stroma with increased glycogen and sialic acid content in the uterus of the chloroform extract treated animals, which are comparable to those of the ovariectomized estrogen treated animals, suggest that the chloroform extract possesses mild estrogenic activity.

• 한국임상수의학회지
• /
• 제20권3호
• /
• pp.369-375
• /
• 2003

The ultrasonography was performed in 77,924 subestrous dairy cows from 680 dairy farms at 57 districts. The cows were examined for confirmation of resumption of ovaries and uterus after 30 days postpartum, for early pregnancy diagnosis after 30 days post-insemination, confirmation of pregnancy at 8 month post-insemination, and for diagnosis of reproductive dysfunctions, respectively. The results of reproductive examination by ultrasonography in 77,924 dairy cows were ovarian disorders 35,452 (46.8%), uterine disorders 10,721 (13.8%), pregnancy and pregnant failure 24,044 (30.8%), adhesion of reproductive tracts 167 (0.2%), freematins 13 (0.01%) and others 6,527 (8.4%) cows, respectively. The 13,732 (49.6%) cows out of 27,694 cows were treated for silent heat or error of estrus detection, 3,473 (12.5%) cows for follicular cysts, 815 (3.0%) cows for luteal cysts, 606 (2.2%) cows for inactive ovaries, 4 (0.01%) cows for granulosa cell tumors, and 6,455 (23.3%) cows for endometritis, respectively. The indices of reproductive efficiencies before (2001-08-10) and after (2003-07-20) periodical examination of reproductive status were as follows; the mean intercalving interval were shortened from 471 days to 383 days, the mean interval calving to conception were shortened from 187 days to 99 days, the mean interval calving to first service were shortened from 105 days to 67 days, the mean cows showing heat by 60 days postpartum were increased from 33% to 89%, the mean conception rate to first service were increased from 43% to 68%, and the mean service per conception were shortened from 2.6 times to 1.8 times, respectively. These results suggest that periodical examination of reproductive status would be useful for the improvement of the reproductive performance in dairy cows.

• 한국수의병리학회:학술대회논문집
• /
• 한국수의병리학회 2003년도 추계학술대회초록집
• /
• pp.31-31
• /
• 2003

Porcine circovirus (PCV) is the smallest virus that replicates autonomously in mammalian cells. PCV2 is recongized as the casual agent of postweaning multisystemic wasting syndrome (PMWS).[1] Although the role of PCV2 in reproductive failure requires further clarification, there have been several reports of PCV2-associated reproductive failure. Consistent clinical signs of affected farms include elevated abortion, stillbirths and fetal mummification. The objective of this study was to determine the prevalence of PCV2 in aborted fetuses and stillborn piglets. Second objective was to determine the distribution of PCV2 DNA and antigen in aborted fetuses and stillborn piglets by in situ hybridisation and immunohistochemistry. (omitted)